Skip to content

Advertisement

  • Poster presentation
  • Open Access

DHEAS and cortisol correlate with Hypothalamic Serotonin-1A Receptors

  • 1,
  • 2,
  • 1,
  • 1,
  • 2, 3,
  • 1,
  • 4,
  • 2,
  • 1 and
  • 1
Annals of General Psychiatry20087 (Suppl 1) :S220

https://doi.org/10.1186/1744-859X-7-S1-S220

  • Published:

Keywords

  • Cortisol
  • Cortisol Plasma Level
  • Dehydroepiandrosterone Sulfate
  • Healthy Female Subject
  • Receptor Binding Potential

Background

Serotonin modulates the activity of the hypothalamic-pituitary-adrenal (HPA) axis, to a big part through the serotonin-1A receptor (5-HT1A) [1]. In return, hormones of the HPA axis, namely dehydroepiandrosterone sulfate (DHEAS) [2] and cortisol have regulatory effects on the serotonergic neurotransmission.

Materials and methods

Eighteen healthy female subjects participated in this PET study. The selective 5-HT1A receptor antagonist [carbonyl-11C]WAY-100635 was used as radioligand. The hypothalamus as an essential part of the HPA axis and eight control regions of interest and the cerebellum as reference region were defined a priori and delineated on co-registered MR images. DHEAS and cortisol plasma levels were ascertained by morning blood collections on the PET day. The 5-HT1A receptor binding potentials of the target brain regions were correlated with DHEAS, cortisol plasma levels and the ratio of DHEAS / cortisol.

Results

We found highly significant correlations between the hypothalamic 5-HT1A receptor binding and DHEAS (p=.003) and the ratio of DHEAS / cortisol (p<.0001), but not with cortisol and not in other brain regions.

Conclusions

The 5-HT1A receptor may influence the DHEAS plasma level by modulating CRH and ACTH release as reported for cortisol before [1]. Vice versa, the interaction of cortisol and DHEAS may exert a regulatory effect on the 5-HT1A receptor distribution in the hypothalamus as a feedback loop. As disturbances of the HPA axis [3] as well as changes of the 5-HT1A receptor distribution [4] have been reported frequently in affective disorders, future studies should aim their focus on these interactions.

Declarations

Acknowledgements

This research was supported by grants from the Austrian National Bank (OENB P11468) and the Medical Science Fund of the City of Vienna (BMF P2515) to R. Lanzenberger, and a grant from the Austrian Science Fund (FWF P16549). The authors are grateful to J. Tauscher, C. Windischberger, A. Becherer, N. Praschak-Rieder, L. Pezawas, M. Willeit, M. Fink, D. Ettlinger, T. Attarbaschi, S. Friedreich, E. Moser, and R. Dudczak for their scientific, medical or administrative support.

Authors’ Affiliations

(1)
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria
(2)
Department of Nuclear Medicine, PET Centre, Medical University of Vienna, Austria
(3)
Department of Pharmaceutical Technology, University of Vienna, Austria
(4)
Clinical Institute for Medical and Chemical Laboratory Diagnostics Endocrinology, Austria

References

  1. Pan L, Gilbert F: Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology. 1992, 56 (6): 797-802. 10.1159/000126332.View ArticlePubMedGoogle Scholar
  2. de Kloet ER, Joels M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005, 6 (6): 463-75. 10.1038/nrn1683.View ArticlePubMedGoogle Scholar
  3. Christensen MV, Kessing LV: The hypothalamo-pituitary-adrenal axis in major affective disorder: a review. Nord J Psychiatry. 2001, 55 (5): 359-63. 10.1080/080394801317080873.View ArticlePubMedGoogle Scholar
  4. Parsey RV: Altered serotonin 1A binding in major depression: a [carbonyl-C-11] WAY100635 positron emission tomography study. Biol Psychiatry. 2006, 59 (2): 106-13. 10.1016/j.biopsych.2005.06.016.View ArticlePubMedGoogle Scholar

Copyright

© Moser et al.; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.

Advertisement